BFC Planning’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Other funds holding RARE
BFC Planning's RARE Position: Q3 2026 in Review
BFC Planning opened a new position in Ultragenyx Pharmaceutical (RARE) in Q3 2026: 225 shares worth $3.38K. The stake represents ﹤0.01% of the portfolio and ranks #2837 among its holdings. This is a return to the name: BFC Planning previously reported a position in RARE as recently as Q1 2026.
BFC Planning first reported a position in RARE in Q3 2025 and has held it in 4 quarters since. 183 funds tracked by Wall St. Rank hold RARE as of Q3 2026.
- BFC Planning held 225 shares of Ultragenyx Pharmaceutical worth $3.38K as of Q3 2026.
- Ultragenyx Pharmaceutical was a new BFC Planning position in Q3 2026.
- Ultragenyx Pharmaceutical made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2837 holding.
- BFC Planning first reported a position in Ultragenyx Pharmaceutical in Q3 2025 and has held it in 4 quarters since.
- 183 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.